Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Abridge, Highmark Health and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health and Novartis. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.

Read More

Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing

Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs to source biotech innovation. This alliance will focus on developing next-generation drugs in the class of targeted cancer therapies called antibody drug conjugates. The post Pfizer’s $10.5B Deal With One…

Read More

Aging is Soon to Be a Preventable Disease

For most of human history, cellular aging was treated as biologically fixed, an inevitable accumulation of damage with no meaningful pathway to reversal. That assumption is no longer tenable. The post Aging is Soon to Be a Preventable Disease appeared first on MedCity News.

Read More

CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act 

CMS finalized a new rule aimed at streamlining the No Surprises Act’s overwhelmed arbitration system. Provider groups largely welcomed the reforms — though some industry leaders said additional changes are still needed to address alleged misuse and improve transparency. The post CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act  appeared first on…

Read More